Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Pharmacokinetic and pharmacodynamic evaluation of linagliptin for the treatment of type 2 diabetes mellitus, with consideration of Asian patient populations - Ceriello_2017_J.Diabetes.Investig_8_19 |
| Author(s) : Ceriello A , Inagaki N |
| Ref : J Diabetes Investig , 8 :19 , 2017 |
| Abstract : Ceriello_2017_J.Diabetes.Investig_8_19 |
| ESTHER : Ceriello_2017_J.Diabetes.Investig_8_19 |
| PubMedSearch : Ceriello_2017_J.Diabetes.Investig_8_19 |
| PubMedID: 27180612 |
| Title : SYR-472, a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor, in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial - Inagaki_2014_Lancet.Diabetes.Endocrinol_2_125 |
| Author(s) : Inagaki N , Onouchi H , Sano H , Funao N , Kuroda S , Kaku K |
| Ref : Lancet Diabetes Endocrinol , 2 :125 , 2014 |
| Abstract : Inagaki_2014_Lancet.Diabetes.Endocrinol_2_125 |
| ESTHER : Inagaki_2014_Lancet.Diabetes.Endocrinol_2_125 |
| PubMedSearch : Inagaki_2014_Lancet.Diabetes.Endocrinol_2_125 |
| PubMedID: 24622716 |